Home Newsfeeds Evercore ISI Group Upgrades Enanta Pharmaceuticals to Outperform, Announces $62 Price Target

Evercore ISI Group Upgrades Enanta Pharmaceuticals to Outperform, Announces $62 Price Target

Evercore ISI Group analyst Liisa Bayko upgrades Enanta Pharmaceuticals (NASDAQ:ENTA) from In-Line to Outperform and announces $62 price target.

byBenzinga Newsdesk

July 6, 2022

1 minute read

Evercore ISI Group analyst Liisa Bayko upgrades Enanta Pharmaceuticals (NASDAQ:ENTA) from In-Line to Outperform and announces $62 price target.

Elon Musk And Vivek Ramaswamy: Beyond Cannabis To Ukraine, Russia, China Politics & Peace

By Maureen Meehan

October 24, 11:06 PM

Vivek Ramaswamy, the only major Republican presidential candidate to publicly support legalizing marijuana and moving toward regulating access to certain psychedelics, is not unlike his friend and supporter&n

TSLA

Airbnb Gears Up For Q1 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

By Avi Kapoor

May 8, 10:03 AM

Airbnb, Inc. (NASDAQ:ABNB) is expected to release earnings results for its first quarter, after the closing bell on…

ABNB

FDA
News

OKYO Pharma Plans Q4 2022 IND Filing Of OK-101 To Treat Dry Eye Disease With Subsequent Phase 2 Initiation

By Benzinga Newsdesk

August 30, 9:06 AM

OK-101 to treat ocular diseases, including Dry Eye Disease (DED), uveitis, allergic conjunctivitis, and ocular pain. Successful pre-IND meeting with FDA in Q1 2022 and novel speed to market potential. IND

OKYO

Western Asset Mortgage Q3 EPS $0.37 Misses $0.65 Estimate, Sales $5.70M Miss $9.17M Estimate

By Benzinga Newsdesk

November 3, 6:47 PM

Western Asset Mortgage (NYSE:WMC) reported quarterly earnings of $0.37 per share which missed the analyst consensus estimate of $0.65 by 43.08 percent. This is a 38.33 percent decrease over earnings of $0.60 per share

WMC

Evercore ISI Group Upgrades Enanta Pharmaceuticals to Outperform, Announces $62 Price Target

Related Posts

Elon Musk And Vivek Ramaswamy: Beyond Cannabis To Ukraine, Russia, China Politics & Peace

Airbnb Gears Up For Q1 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

OKYO Pharma Plans Q4 2022 IND Filing Of OK-101 To Treat Dry Eye Disease With Subsequent Phase 2 Initiation

Western Asset Mortgage Q3 EPS $0.37 Misses $0.65 Estimate, Sales $5.70M Miss $9.17M Estimate